跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
SFDA
/
TRELEGY ELLIPTA 100/62.5/25MCG Inhalation powder, pre-dispensed
Authorized
NCE
TRELEGY ELLIPTA 100/62.5/25MCG Inhalation powder, pre-dispensed
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
eee2263d8d826494
Company
Unknown
Type
NCE
Approval Details
Approval Id
eee2263d8d826494
Drug Approval Sfda Name
TRELEGY ELLIPTA 100/62.5/25MCG Inhalation powder, pre-dispensed
Trade Name
TRELEGY ELLIPTA 100/62.5/25MCG Inhalation powder, pre-dispensed
Generic Name
FLUTICASONE FUROATE,UMECLIDINIUM BROMIDE,VILANTEROL
Register Number
3001256785
Register Year
2018
Drug Type
NCE
Route Of Administration
Inhalation use
Package Type
Inhaler
Package Size
1
Size
30
Size Unit
dose
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store below 30°c
Shelf Life
24 Months
Distribution Site
Pharmacy
Description Code
21000004245-187.5-100000073840
Price
236.8
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
eee2263d8d826494
Type
NCE
Back to SFDA Approvals
TRELEGY ELLIPTA 100/62.5/25MCG Inhalation powder, pre-dispensed - SFDA Drug Approval Details